These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2129121

  • 1. Five years' experience with gamma-L-glutamyl-L-dopa: a relatively renally specific dopaminergic prodrug in man.
    Lee MR.
    J Auton Pharmacol; 1990; 10 Suppl 1():s103-8. PubMed ID: 2129121
    [Abstract] [Full Text] [Related]

  • 2. (+)-sulpiride antagonises the renal effects of gamma-L-glutamyl-L-dopa in man.
    MacDonald TM, Jeffrey RF, Freestone S, Lee MR.
    Br J Clin Pharmacol; 1988 Feb; 25(2):203-12. PubMed ID: 3129007
    [Abstract] [Full Text] [Related]

  • 3. Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa.
    Worth DP, Harvey JN, Brown J, Worral A, Lee MR.
    Br J Clin Pharmacol; 1986 May; 21(5):497-502. PubMed ID: 3087398
    [Abstract] [Full Text] [Related]

  • 4. The effect of lithium on the renal response to the dopamine prodrug gludopa in normal man.
    Jeffrey RF, Macdonald TM, Brown J, Rae PW, Lee MR.
    Br J Clin Pharmacol; 1988 Jun; 25(6):725-32. PubMed ID: 2849472
    [Abstract] [Full Text] [Related]

  • 5. The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man.
    Jeffrey RF, MacDonald TM, Marwick K, Lee MR.
    Br J Clin Pharmacol; 1988 Feb; 25(2):195-201. PubMed ID: 3129006
    [Abstract] [Full Text] [Related]

  • 6. DA-1 receptors mediate renal effects of the dopamine prodrug, gludopa, in conscious rabbits.
    Wang ZQ, Way D, Trigg L, McGrath BP.
    Clin Exp Pharmacol Physiol; 1992 May; 19(5):369-72. PubMed ID: 1521369
    [Abstract] [Full Text] [Related]

  • 7. gamma-L-Glutamyl-L-dopa is a dopamine pro-drug, relatively specific for the kidney in normal subjects.
    Worth DP, Harvey JN, Brown J, Lee MR.
    Clin Sci (Lond); 1985 Aug; 69(2):207-14. PubMed ID: 3933890
    [Abstract] [Full Text] [Related]

  • 8. Effect of prolonged intravenous infusion of gludopa in humans and a preliminary study of its oral bioavailability.
    Freestone S, Ellis R, MacDonald TM, Lee MR.
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):126S-129S. PubMed ID: 2116808
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the renal actions of gamma-L-glutamyl-L-dopa and gamma-L-glutamyl-L-tyrosine in normal man.
    Jeffrey RF, MacDonald TM, Lee MR.
    Clin Sci (Lond); 1988 Jan; 74(1):37-40. PubMed ID: 3123118
    [Abstract] [Full Text] [Related]

  • 10. The renal and haemodynamic effects of a 10 h infusion of glutamyl-L-dopa in normal man.
    MacDonald TM, Jeffrey RF, Lee MR.
    Br J Clin Pharmacol; 1989 Jun; 27(6):811-22. PubMed ID: 2527048
    [Abstract] [Full Text] [Related]

  • 11. Metabolism and vascular effects of gamma-L-glutamyl-L-dopa on the isolated rat kidney.
    Barthelmebs M, Caillette A, Ehrhardt JD, Velly J, Imbs JL.
    Kidney Int; 1990 Jun; 37(6):1414-22. PubMed ID: 1972967
    [Abstract] [Full Text] [Related]

  • 12. Patients with essential hypertension have an exaggerated natriuretic response to the dopamine pro-drug glutamyl-dopa.
    Worth DP, Harvey JN, Brown J, Lee MR.
    J Hypertens Suppl; 1985 Dec; 3(3):S179-81. PubMed ID: 2856699
    [Abstract] [Full Text] [Related]

  • 13. Effect of gamma-L-glutamyl-L-dopa on phosphate excretion.
    Sadiq S, Berndt TJ, Nath KA, Knox FG.
    J Lab Clin Med; 2000 Jan; 135(1):52-6. PubMed ID: 10638694
    [Abstract] [Full Text] [Related]

  • 14. Suppression of noradrenaline spillover by the dopamine prodrug gamma-L-glutamyl-L-dopa: a central effect?
    McGrath BP, Wang ZQ, Shimizu K, Way D, Secombe J.
    Hypertens Res; 1995 Jun; 18 Suppl 1():S113-8. PubMed ID: 8529039
    [Abstract] [Full Text] [Related]

  • 15. The dopamine prodrug, gludopa, decreases both renal and extrarenal noradrenaline spillover in conscious rabbits.
    Wang ZQ, Shimizu K, Way D, Secombe J, McGrath BP.
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):365-8. PubMed ID: 8324926
    [Abstract] [Full Text] [Related]

  • 16. Regional haemodynamic effects of dopamine and its prodrugs L-dopa and gludopa in the rat and in the glycerol-treated rat as a model for acute renal failure.
    Drieman JC, van Kan FJ, Thijssen HH, van Essen H, Smits JF, Struijker Boudier HA.
    Br J Pharmacol; 1994 Apr; 111(4):1117-22. PubMed ID: 8032598
    [Abstract] [Full Text] [Related]

  • 17. Renal metabolism and effects of the glutamyl derivatives of L-dopa and 5-hydroxytryptophan in man.
    Li Kam Wa TC, Freestone S, Samson RR, Johnston NR, Lee MR.
    Clin Sci (Lond); 1996 Aug; 91(2):177-85. PubMed ID: 8795441
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics, bioavailability, metabolism, tissue distribution and urinary excretion of gamma-L-glutamyl-L-dopa in the rat.
    Cummings J, Matheson LM, Maurice L, Smyth JF.
    J Pharm Pharmacol; 1990 Apr; 42(4):242-6. PubMed ID: 1974290
    [Abstract] [Full Text] [Related]

  • 19. Beneficial acute effects of selective modulation of renal dopamine system by gamma-L-glutamyl-L-dopa in rabbits with congestive heart failure.
    Wang ZQ, Way D, Shimizu K, Fong F, Trigg L, McGrath BP.
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):1004-11. PubMed ID: 7687706
    [Abstract] [Full Text] [Related]

  • 20. [Metabolism and vascular effects of gammaglutamyl L-dopa on the isolated kidney of the rat].
    Caillette A, Schmidt M, Ehrhardt JD, Imbs JL.
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():179-82. PubMed ID: 3142404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.